Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Institute for Systems Biology
AddedFeb 15, 2024
UpdatedJun 28, 2026
Institute for Systems Biology

Institute for Systems Biology

Series B

ISB: A non-profit institute conducting biomedical research for cures and prevention of diseases and cancers.

HQ
Seattle, WA, US
Founded
2000
Overview
Compare
Fundraising
Employees
Website

The Institute for Systems Biology (ISB) is a non-profit organization dedicated to conducting biomedical research aimed at developing cures, treatments, and preventive measures for cancers, diseases, and environmental issues. ISB focuses on a multimodal approach that integrates personal data, lifestyle factors, cognitive training, and systems medicine, rigorously testing these methods in clinical trials to address and potentially reverse neurological conditions.

ISB has made significant strides in the field of precision medicine, including pioneering research in microbiome-informed nutrition. Its collaborative network of partners enhances its ability to innovate and implement new medical approaches. The institute's impact is evident in its contributions to advancing scientific understanding and improving health outcomes through its research initiatives.

Institute for Systems Biology - Similar Companies

Systems Biology Research Group logo

Systems Biology Research Group

Ibbr logo

Ibbr

Scripps Research Institute logo

Scripps Research Institute

scripps.edu

InVivo Biosystems logo

InVivo Biosystems

Novartis Institutes For Biomedical Research logo

Novartis Institutes For Biomedical Research

novartis.com

InSyBio logo

InSyBio

insybio.gr

Scripps Translational Science Institute logo

Scripps Translational Science Institute

stsiweb.org

HI-Bio logo

HI-Bio

hibio.com

MIT Center for Biomedical Innovation logo

MIT Center for Biomedical Innovation

cbi.mit.edu

Insightful Science logo

Insightful Science

Seven Bridges logo

Seven Bridges

sevenbridges.com

eBioinformatics logo

eBioinformatics

Inception IBD logo

Inception IBD

Corundum Systems Biology logo

Corundum Systems Biology

csb.co.jp

ISI Life Sciences logo

ISI Life Sciences

Institute for Systems Biology - Quick Facts

Who are Institute for Systems Biology's competitors?

Companies similar to Institute for Systems Biology include Systems Biology Research Group, Ibbr, Scripps Research Institute and InVivo Biosystems.

When was Institute for Systems Biology founded?

Institute for Systems Biology was founded in 2000.

Where is Institute for Systems Biology's headquarters located?

Institute for Systems Biology's headquarters is located in Seattle, WA, US.

When was Institute for Systems Biology's last funding round?

Institute for Systems Biology's most recent funding round was for $13M (USD) in September 2022.

How much has Institute for Systems Biology raised to-date?

As of Sep 22, 2022, Institute for Systems Biology has raised a total of $13M (USD).

How many employees does Institute for Systems Biology have?

Institute for Systems Biology has 230 employees as of Feb 4, 2024.

Institute for Systems Biology - Classification

Technology
  • Analytics
Geographic Exposure
  • Global
Customer
  • Enterprise
  • Government
  • Non-Profit
Main Product
  • Biomedical Research
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 23 more industry codes
NAICS
  • 513200Software Publishers
  • 610000Educational Services
  • 611300Colleges, Universities, and Professional Schools
  • 611310Colleges, Universities, and Professional Schools
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 611000Educational Services
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 8220Colleges, Universities, Professional Schools, And Junior Colleges
  • 8221Colleges, Universities, And Professional Schools
  • 8000Health Services
  • 8200Educational Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8290Schools And Educational Services, Not Elsewhere Classified
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research